Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.26
-0.45 (-2.28%)
At close: Nov 7, 2025, 4:00 PM EST
19.29
+0.03 (0.16%)
After-hours: Nov 7, 2025, 7:58 PM EST
Apellis Pharmaceuticals Employees
As of December 31, 2024, Apellis Pharmaceuticals had 710 total employees, including 705 full-time and 5 part-time employees. The number of employees increased by 4 or 0.57% compared to the previous year.
Employees
710
Change (1Y)
4
Growth (1Y)
0.57%
Revenue / Employee
$1,431,545
Profits / Employee
$63,361
Market Cap
2.44B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 710 | 4 | 0.57% |
| Dec 31, 2023 | 706 | -61 | -7.95% |
| Dec 31, 2022 | 767 | 291 | 61.13% |
| Dec 31, 2021 | 476 | 102 | 27.27% |
| Dec 31, 2020 | 374 | 139 | 59.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
APLS News
- 3 days ago - Apellis Pharmaceuticals to Present at the Stifel 2025 Healthcare Conference - GlobeNewsWire
- 9 days ago - Apellis Pharmaceuticals, Inc. (APLS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 19 days ago - New One-Year Data Reinforcing the Robust and Sustained Efficacy of EMPAVELI® (pegcetacoplan) in C3G and Primary IC-MPGN to be Presented at ASN Kidney Week - GlobeNewsWire
- 23 days ago - Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders - Seeking Alpha
- 2 months ago - Apellis Pharmaceuticals, Inc. (APLS) Presents At Baird Global Healthcare Conference (Transcript) - Seeking Alpha
- 2 months ago - Apellis Pharmaceuticals, Inc. (APLS) Presents At Cantor Global Healthcare Conference 2025 (Transcript) - Seeking Alpha